Investments
31Portfolio Exits
3
Want to inform investors similar to Huimei Investment about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Huimei Investment Investments
31 Investments
Huimei Investment has made 31 investments. Their latest investment was in AmVisionBio as part of their Series A - II on March 3, 2023.
Huimei Investment Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
3/9/2023 | Series A - II | AmVisionBio | $14.4M | No | 3 | |
3/8/2023 | Seed VC - II | Xinrui Medical | Yes | 2 | ||
1/20/2023 | Series B | S&P Filtration | Yes | 1 | ||
1/12/2023 | Series C | |||||
10/28/2022 | Series A |
Date | 3/9/2023 | 3/8/2023 | 1/20/2023 | 1/12/2023 | 10/28/2022 |
|---|---|---|---|---|---|
Round | Series A - II | Seed VC - II | Series B | Series C | Series A |
Company | AmVisionBio | Xinrui Medical | S&P Filtration | ||
Amount | $14.4M | ||||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 3 | 2 | 1 |
Huimei Investment Portfolio Exits
3 Portfolio Exits
Huimei Investment has 3 portfolio exits. Their latest portfolio exit was R&G PharmaStudies on August 02, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/2/2022 | IPO | Public | 3 | ||
Date | 8/2/2022 | ||
|---|---|---|---|
Exit | IPO | ||
Companies | |||
Valuation | |||
Acquirer | Public | ||
Sources | 3 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.